New crystalline form of a cyclopropyl benzamide derivative

Details for Australian Patent Application No. 2011218492 (hide)

Owner AstraZeneca AB

Inventors Uczynski, Michael A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011218492

PCT Pub. Number WO2011/102795

Priority 61/305,583 18.02.10 US

Filing date 17 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 295/192 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/18 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/102795 Priority application(s): WO2011/102795

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218494-Method and arrangement at trucks for tipping a loading bin

2011218491-Processes for making cyclopropyl amide derivatives and intermediates associated therewith